Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Strivectin Operating Company
WARNING LETTER
•Strivectin Operating Company

Strivectin Operating Company – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to StriVectin Corporate Headquarters after reviewing their website, strivectin.com, in December 2014. The FDA determined that two products, "Potent Wrinkle Reducing Treatment" and "TL Advanced Tightening Neck Cream," are unapproved new drugs under the Federal Food, Drug, and Cosmetic Act.

The products are deemed drugs because their website claims indicate they are intended to affect the structure or function of the human body. Examples of such claims include "Clinically proven to change the anatomy of a wrinkle," "Potent elastin-stimulating peptides help enhance skin structure," and "[F]eatures breakthrough Gravitite-CF Lifting Complex to restore the elastin fiber architecture, providing noticeable lift and improving resistance to gravity."

These products are considered "new drugs" because they are not generally recognized as safe and effective for their claimed uses. Under Section 505(a) of the Act, new drugs cannot be legally marketed in the U.S. without prior FDA approval via a New Drug Application (NDA).

StriVectin was requested to take prompt action to correct the violations and notify the FDA in writing within fifteen working days of receipt of the letter, detailing the specific steps taken to correct the violations and prevent recurrence. Failure to comply could result in enforcement actions such as injunctions or product seizure.

Company
Strivectin Operating Company
Product type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • William A. Correll (Director)
View Company Profile

ID · 69244b1f-f561-4dd4-a6ce-07e005f1318b

Violation Codes3
21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21.U.S.C. 355(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Strivectin Operating Company
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.